Diabetes Pills

April 4th, 2011 by admin1

A recent study in the New England Journal of Medicine proves that Actos, a new diabetes medicine, slows the progress of pre-diabetes to diabetes. Matthew Herper of Forbes Magazine tells readers that not only was the study paid for by Actos’ manufacturer Takeda, but also that people on Actos were significantly more likely to develop side effects, that include fluid buildup, weight gain and heart problems. Three deaths occurred in the Actos group next to one in the placebo group.
Actos did, however, cut back on the number of cases of diabetes by 72%.
Avandia has also been proven effective in slowing diabetes, but sales have been pulled back due to heart problems.

James Stein of the University of Wisconsin says the idea of preventing diabetes a “sleight of hand” by drug companies. Herper says, “What’s the difference between calling someone diabetic and putting them on medicine? It’s not like slowing the diagnosis of diabetes has been shown to prevent the eye, kidney or heart problems that can eventually be caused by the disease.”